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The purpose of this study was to determine the role of ICAM-1 in ocular herpes simplex virus type 1 (HSV-1) infection.
Wild-type and ICAM-1 knockout mice were assessed for resistance to ocular HSV-1 infection in the presence of naked DNA
plasmid vector or plasmid DNA encoding interferon-a1 topically applied to the cornea of the mice. Wild-type mice showed
greater resistance to HSV-1 infection compared to ICAM-1 knockout mice as measured by cumulative survival. The absence
of ICAM-1 did not affect the efficacy of the interferon-a1 transgene against ocular HSV-1. Both ICAM-1 and wild-type mice
treated with the transgene showed a reduction in viral load and antigen expression in the trigeminal ganglion compared to
the plasmid vector-treated counterparts. In contrast, the presence of the transgene reduced the number of infiltrating cells
into the cornea in comparison to plasmid vector DNA controls in the wild-type mice but not in the ICAM-1 knockout mice.
Collectively, these results suggest that the IFN-a1 transgene can restore resistance against HSV-1 infection in ICAM-1-
deficient mice. © 2001 Academic Press
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aINTRODUCTION
Herpes simplex virus type-1 (HSV-1) infection of the
cornea results in a strong inflammatory response as a
result of the local production of cytokines and chemo-
kines (Hendricks et al., 1992; Staats and Lausch, 1993;
Su et al., 1996; He et al., 1999). The sequential expression
f these mediators promotes the extravasation of leuko-
ytes from the circulation into the cornea including neu-
rophils, natural killer (NK) cells, and CD41 T lympho-
ytes. Neutrophils are thought to initially enter the cor-
ea (Metcalf and Reichert, 1979; Meyers-Elliot and
hitjian, 1981), where they have been shown to control
SV-1 replication and spread (Tumpey et al., 1996;
Thomas et al., 1997). NK cells have been implicated in
promoting herpes keratitis by facilitating neutrophil traf-
ficking into the cornea (Tamesis et al., 1994; Bouley et al.,
1996). CD41 T cells are reported to be the only T cell
population found to occur in the eye during acute HSV-1
infection (Niemialtowski and Rouse, 1992) and are
thought to be central in orchestrating herpes stromal
keratitis (Gangappa et al., 1998; Thomas and Rouse,
1998; Verjans et al., 1998). Herpetic stromal keratitis is
erhaps the most common sight-threatening manifesta-
ion of ocular HSV and is linked to leukocyte infiltration.
dramatic reduction in herpes-induced keratitis is
1 To whom correspondence and reprint requests should be ad-t
ressed at Department of Ophthalmology, Dean McGee Eye Institute,
UHSC, 608 Stanton L Young Blvd., Oklahoma City, OK 73104.
69hown in macrophage inflammatory protein-1a knockout
ice corresponding with a reduction in infiltrating neu-
rophils and CD41 T cells (Tumpey et al., 1998).
The influx of leukocytes into the inflamed eye is pro-
moted by the local production of chemokines including
macrophage inflammatory protein-2 and interferon
(IFN)-g eliciting the expression of adhesion molecules on
the surface of the endothelium (Butcher, 1990; Tang and
Hendricks, 1996; Yan et al., 1998). Both CD31 (platelet
endothelial cell adhesion molecule-1, (PECAM-1) and
CD54 (intercellular adhesion molecule-1, ICAM-1) are
upregulated in ocular tissue following HSV-1 infection
(Tang and Hendricks, 1996) and are thought to be influ-
ential in the adherence (ICAM-1) (Sewart et al., 1996) and
ransendothelial migration (PECAM-1) (Berman et al.,
996) of the leukocyte. For example, the absence of
CAM-1 has been found to impair inflammation in mice
Sligh et al., 1993; Bullard et al., 1996). However, ICAM-1
also serves as a potent costimulatory molecule associ-
ated with antigen presentation (Dubey et al., 1995), in-
ucing T cell proliferation and IL-2 production in the
bsence of B7 costimulation (Gaglia et al., 2000). The
present study was undertaken to determine whether the
presence of ICAM-1 was required for resistance to ocu-
lar HSV-1 infection. In addition, we also addressed the
issue of whether the introduction of a plasmid DNA
encoding IFN-a1 could override any anti-viral deficiency
observed in ICAM-1 knockout mice. To this end, previous
studies have found that the IFN-a1 transgene applied to
he cornea prior to or immediately after HSV-1 infection
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70 NOISAKRAN, HA¨RLE, AND CARRantagonizes viral replication and spread (Noisakran et
al., 1999; Noisakran and Carr, 2000a).
RESULTS AND DISCUSSION
Susceptibility of ICAM-1 knockout mice to ocular
HSV-1 infection
Previous results have found ICAM-1 expression on
vascular endothelium in corneal tissue to be upregulated
following HSV-1 infection (Tang and Hendricks, 1996). We
interpret these results to suggest that ICAM-1 is involved
in facilitating the local immune response to the virus by
promoting leukocyte tethering to the endothelium and
subsequent transendothelial migration to the inflamed
area as well as the costimulatory properties it pos-
sesses. To test this hypothesis, wild-type (WT) and
ICAM-1 knockout (ko) mice were ocularly infected with
HSV-1 and surveyed for cumulative survival. The results
show a significant reduction in the rate of survival fol-
lowing infection with HSV-1 in the ICAM-1 ko mice com-
pared to the WT controls (Fig. 1). Since ICAM-1 is ex-
pressed on leukocytes, endothelial cells, keratinocytes,
and fibroblasts (van de Stolpe and van der Saag, 1996),
the susceptibility of ICAM-1 ko mice to HSV-1 infection
could be due to the absence of expression on leukocytes
or nonimmune cells. To investigate this issue, spleen
cells from WT mice were adoptively transferred to
ICAM-1 ko recipients prior to infection. Similar to mock-
treated ICAM-1 ko mice, ICAM-1 ko mice receiving WT
spleen cells succumbed to ocular HSV-1 infection to an
FIG. 1. ICAM-1 knockout mice are susceptible to ocular HSV-1
infection. ICAM-1 knockout (ICAM 2/2) and wild-type (WT) mice (n 5
19/group) were ocularly infected with 1000 pfu/eye HSV-1 and moni-
tored for cumulative survival. *P , 0.05 comparing the WT to ICAM-1
nockout mice. This figure is a summary of four experiments, n 5 4–5
ice/experiment. Bars represent standard error.equivalent level, suggesting that the deficiency of
ICAM-1 expression is not solely at the effector cell level
e
d(Fig. 2). However, ICAM-1 expression is required on
leukocytes to effectively resist succumbing to the infec-
tion. Specifically, the adoptive transfer of WT but not
ICAM-1 ko spleen cells into T cell receptor (TCR)-b chain
ko recipients (highly sensitive to ocular HSV-1 infection,
unpublished observation) prior to viral infection shows
that only WT spleen cell recipients have an increased
survival rate to the infection (Fig. 2). Collectively, these
results suggest that ICAM-1 expression is necessary on
both the nonimmune and the immune cells to provide
maximum resistance to ocular HSV-1 infection. These
results are consistent with a previous study that found
that administering antibody to ICAM-1 rendered mice
susceptible to lethal encephalitis following corneal infec-
tion with HSV-1 (Dennis et al., 1995).
ICAM-1 is not required for IFN-a1 transgene efficacy
Since ICAM-1 ko mice were highly sensitive to ocular
HSV-1 infection, the question was raised as to whether
the susceptibility of these mice to infection could be
overcome by the topical application of a plasmid DNA
encoding IFN-a1 onto the cornea of the animal. IFN-a
has previously been shown to promote a TH1 response
(Parronchi et al., 1992) and reduce the potential for the
development of TH2 T lymphocytes and their products
(e.g., IL-4) that tend to exacerbate HSV-1 infection (Jama-
raman et al., 1993; Ikemoto et al., 1995). In comparing WT
to ICAM-1 ko mice receiving a plasmid DNA encoding
IFN-a1 prior to infection, there was a modest but insig-
FIG. 2. ICAM-1 is required on leukocytes for resistance to ocular
HSV-1 infection. ICAM-1 knockout (ICAM2/2), T cell receptor b chain
nockout (TCRb2/2) or wild-type (WT) mice (n 5 8–10/group) re-
ceived either medium or medium containing 2 3 107 spleen cells (SC)
from WT or ICAM-1 knockout mice. Mice were subsequently infected
with 1000 pfu/eye HSV-1 and monitored for cumulative survival. *P ,
0.05 comparing WT spleen cell, TCRb2/2 recipients to ICAM2/2
pleen cell, TCRb2/2 recipients. This figure is a summary of two
xperiments, n 5 4–5 mice/group/experiment. Bars represent stan-
ard error.
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71ICAM-1, INTERFERON-a1, AND HERPES SIMPLEX VIRUS TYPE 1nificant decrease in the survival rate of the ICAM-1 ko
animals (Fig. 3). However, in the presence of the IFN-a1
transgene, WT and ICAM-1 ko mice were more resistant
to HSV-1 infection in comparison to the WT and ICAM-1
ko mice receiving the plasmid vector alone (Fig. 3). (In a
separate study, preliminary results suggest that different
subtypes of IFN-a display a wide range of efficacy
gainst ocular HSV-1 [Carr and Lawson, unpublished
bservation]). Coinciding with this result, WT or ICAM-1
o mice treated with the DNA encoding IFN-a1 showed
a significant reduction in infectious virus recovered from
the eye in comparison to mice treated with the plasmid
vector alone 6 days postinfection (Fig. 4). However, there
was no difference in viral loads in the eyes of the ICAM-1
ko or WT mice treated with plasmid vector in comparison
to animals treated with the IFN-a1 transgene at 3 days
postinfection (data not shown).
Since viral loads and, therefore, antigen stimuli were
significantly reduced in the mouse eye treated with the
DNA encoding IFN-a1, it was hypothesized that the cel-
lular infiltration into the infected corneas would also be
reduced in the transgene-treated groups compared to
their respective counterparts treated with the vector
alone. WT mice treated with the IFN-a1 transgene
showed a significant reduction in infiltrating cells in the
cornea in comparison to WT mice treated with the plas-
mid vector on days 6 and 20 postinfection (Table 1).
FIG. 3. Topical application of DNA encoding murine IFN-a1 aug-
ments survival of wild-type or ICAM-1 knockout mice infected with
HSV-1. Plasmid DNA vector alone (vector) or DNA encoding IFN-a1
(IFN-a) was topically applied to the eye of wild-type (wt) or ICAM-1
knockout (ICAM2/2) mice and, 24 h later, the mice were infected with
1000 pfu/eye HSV-1 (McKrae strain) and monitored for cumulative
survival. *P , 0.05 comparing the IFN-a1 transgene-treated group to
their counterparts treated with the plasmid vector alone. This figure is
a summary of two (wt) or four (ICAM2/2) experiments with n 5 4–5
mice/group/experiment.However, there was no difference in the number of cells
infiltrating the corneal stroma in the ICAM-1 mice treatedwith the transgene in comparison to the vector-treated
controls at 6- or 20-day time points postinfection (Table
1). However, the presence of ICAM-1 may play a role in
tissue integrity during infection. Specifically, the squa-
mous, wing, and basal cells of the epithelial layers of the
cornea looked remarkably normal in presentation in the
WT mice on day 6 postinfection (Fig. 5). In contrast, the
basal and winged cell layers of the epithelium of ICAM-1
mice were distorted, with gross morphological changes
evident in the vector-treated group more so than in the
IFN-a1 transgene-treated group (Fig. 5). Although earlier
ime points were also investigated (days 2 and 3 postin-
ection), few cellular infiltrates were observed in any of
he treated WT or ICAM-1 ko mice, making quantitative
ifferences difficult to assess (data not shown).
ntagonism of HSV-1 replication in the trigeminal
anglion by the IFN-a1 transgene
Upon replication in the corneal epithelium, HSV-1 is
transported back into the neuronal cell bodies of the
FIG. 4. IFN-a1 construct inhibits viral replication in the eyes and
trigeminal ganglia of HSV-1 infected wild-type (WT) and ICAM-1 knock-
out (ICAM KO) mice day 6 postinfection. Mice were topically treated
with 100 mg/eye of either plasmid vector alone (V) or plasmid DNA
ontaining the IFN-a1 transgene 24 h prior to infection with HSV-1
(1000 pfu/eye). At 6 days postinfection, the eyes and trigeminal ganglia
were removed, weighed, and homogenized. The homogenate was
centrifuged (10,000 g, 5 min) and the clarified supernatants were
assayed for virus titers by plaque assay. Results are reported as the
mean 6 SEM from six mice/group representing two experiments. *P ,
0.05 comparing the IFN-a1 transgene-treated mice to the vector-
treated animals in each group.
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72 NOISAKRAN, HA¨RLE, AND CARRtrigeminal ganglion (TG) by retrograde axoplasmic flow
(Izumi and Stevens, 1990). In addition, the mortality as-
sociated with HSV-1 infection in mice is typically due to
the trafficking of the virus from the peripheral nervous
system to the central nervous system, often resulting in
fulminating disease, ultimately leading to encephalitis
and death. Viral spread in the nervous system is con-
trolled by infiltrating leukocytes primarily composed of
CD81 T lymphocytes and g/d T cells (Simmons and
Tscharke, 1992; Shimeld et al., 1995; Liu et al., 1996;
Sciammas et al., 1997). These and other cells secrete
IFN-g, a cytokine previously shown to play a key role in
ontrolling HSV-1 and enhancing neuronal cell survival
ollowing infection (Cantin et al., 1995, 1999; Geiger et al.,
995, 1997). Since ICAM-1 induces T lymphocyte trans-
ndothelial migration through brain endothelial cells (Ad-
mson et al., 1999), it is hypothesized that the lethal
ffect of HSV-1 in the ICAM-1 ko mice is due to the
eplication and spread of the virus to the peripheral (TG)
nd central nervous system. To investigate this possibil-ty, TG from ICAM-1 ko and WT mice treated with theTABLE 1
Cellular Infiltration of Cornea Following HSV-1 Infectiona
Treatment
Day 6
postinfection
Day 20
postinfection
WT (plasmid vector) 107 6 16b 465 6 114
T (IFN-a1 transgene) 60 6 4* 267 6 14*
ICAM-1 ko (plasmid vector) 113 6 8 415 6 47
ICAM-1 ko (IFN-a1 transgene) 147 6 23 315 6 9
a Wild-type (WT) or ICAM-1 knockout (ICAM-1 ko) mice (n 5 4/group)
were treated with 100 mg DNA/eye of either plasmid vector alone or
plasmid containing the IFN-a1 transgene and subsequently infected
with HSV-1 (1000 pfu/eye) 24 h later. At the indicated time postinfection,
the mice were sacrificed and the eyes were collected, fixed, and
processed for hematoxylin–eosin staining. Infiltrating cells were enu-
merated from four serial sections/sample/animal for a total of 16 sam-
ples/treatment. *P , 0.05 comparing this group to all other groups
within the same timepoint (except ICAM-1 to ko 1 IFN-a1 transgene
treatment day 20 postinfection). Uninfected WT mice had 39 6 2.9
cells/section counted compared to 25 6 2.4 cells/section for uninfected
CAM-1 ko mice. All infected mice had significantly (P , 0.01) elevated
umbers of infiltrating cells in the cornea.
b Numbers represent means 6 SEM.
lasmid vector alone or plasmid containing the IFN-a1FIG. 5. IFN-a1 transgene treatment reduces the infiltration of cells into the cornea of wild-type but not ICAM-1 knockout mice. Mice were topically
treated with either the plasmid vector (vector) or the plasmid DNA encoding IFN-a1 (pCMV-IFNa1) 24 h prior to corneal infection with HSV-1 (1000
pfu/eye). The eyes were removed from infected or uninfected (control) mice 6 days postinfection, and the tissue was cross-sectioned and processedons counted/treatment/group with the summary results presented in
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73ICAM-1, INTERFERON-a1, AND HERPES SIMPLEX VIRUS TYPE 1transgene were assayed for infectious virus at times
postinfection. Although there was no significant differ-
ence in the viral load in the TG comparing the vector- to
transgene-treated groups 3 days postinfection, there
was a significant reduction in recoverable virus from this
tissue at day 6 postinfection in mice (WT or ICAM-1 ko)
treated with the transgene in comparison to the corre-
sponding plasmid-vector-treated group (Fig. 4). This dif-
ference was also found by immunohistochemical stain-
ing of TG for HSV-1 antigen. Specifically, WT and ICAM-1
ko mice topically administered the IFN-a1 transgene in
the cornea showed a reduction in HSV-1 antigen staining
in the TG 6 days postinfection in comparison to mice
treated with the plasmid vector (Fig. 6). Collectively,
these results suggest that ICAM-1 deficiency modifies
the host response to viral infection, enhancing vulnera-
bility to viral replication and spread in the nervous sys-
tem. One potential candidate affected by a disrupted
CD54/CD18 association is IL-6. IL-6 is induced within the
central nervous system by ICAM-1 ligation (Lee et al.,
2000) and is associated with resistance to HSV-1 (Carr
and Campbell, 1999; LeBlanc et al., 1999). Therefore, in
the absence of ICAM-1, the host would be more suscep-
tible to HSV-1 infection due to a lack of IL-6. However, in
the presence of the IFN-a1 transgene, the host is capa-
le of controlling replication initially in the eye and sub-
FIG. 6. Topical application of plasmid DNA encoding IFN-a1 to the ey
r ICAM-1 knockout (ICAM12/2) mice were treated with plasmid vec
4 h prior to infection with 1000 pfu/eye HSV-1. The mice (n 5 4/group)
nd assessed for the presence of HSV-1 antigen by indirect immunohi
negative controls. Results are representative of two experiments withequently in the nervous system by directly antagonizing
iral replication.
cntibody titers to HSV-1 in ICAM-1 knockout and
ild-type mice
Previous results have shown that the administration of
eutralizing antibodies to type I IFN significantly en-
ances the anti-HSV-1 antibody titers in virally infected
ice (Halford et al., 1997). Therefore, it was reasoned
hat by introducing an exogenous source of type I IFN in
he form of a plasmid construct into mice that reduces
he viral load and antigen expression in infected tissue,
reduction in antibody titer to HSV-1 would follow. To
ubstantiate this predicted outcome, WT and ICAM-1 ko
ice that survived into latency (i.e., day 30 postinfection)
ere assessed for anti-HSV-1 antibody titers. The results
how that WT mice treated with the plasmid construct
ncoding IFN-a1 had a significant reduction in total (Fig.
A) and IgG2a (Fig. 7B) antibody titers to HSV-1 com-
ared to all other groups. However, the ICAM-1 ko mice
reated with the IFN-a1 transgene had titers similar to
the vector-treated WT and ICAM-1 ko mice and signifi-
cantly higher than the WT IFN-a1 transgene-treated co-
orts (Figs. 7A and 7B). There were no significant differ-
nces in the anti-HSV-1 IgG1 titers comparing all groups
f treated mice (data not shown). These results suggest
hat the transgene-treated ICAM-1 ko mice did not man-
ge the viral infection to the same degree as the WT
nimals. Antibody titers tended to parallel the corneal
gonizes HSV-1 antigen expression in the trigeminal ganglion. Wild-type
e (Vector) or plasmid containing the IFN-a1 transgene (pCMV-IFNa1)
acrificed day 6 postinfection and the trigeminal ganglia were collected
mical staining. Uninfected trigeminal ganglia (n 5 2/group) served as
presentations. Original magnification, 4003.es anta
tor alon
were sell infiltration with WT mice treated with the IFN-a1
transgene showing a significant reduction in cellular
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74 NOISAKRAN, HA¨RLE, AND CARRinfiltration as well as a reduction in anti-HSV-1 titers
compared to all other groups.
In summary, the present study show significant anti-
viral, prophylactic effects of the topical application of
DNA encoding IFN-a1 onto the corena of mice subse-
uently infected with HSV-1. These results are consistent
ith earlier studies showing the dynamic nature of type
IFNs and ocular HSV-1 infection (Su et al., 1990; Hen-
ricks et al., 1991) and suggest that IFN-a1 can substi-
ute for immune deficiencies as a result of ICAM-1 gene
isruption in animals infected with HSV-1.
MATERIALS AND METHODS
nimals, cells, and virus
Four- to five-week old male C57BL/6J (wild type),
57BL/6J-Icam-1tm1Bay (ICAM-1 knockout), and C57BL/6J-
crbtm1Mom (T cell receptor b chain [TCRb] ko) mice were
btained from The Jackson Laboratory (Bar Harbor, ME).
ll experiments complied with the ARVO statement for
he Use of Animals in Ophthalmic and Vision Research.
SV-1 (McKrae strain) viral stock was prepared as de-
cribed previously (Halford et al., 1996). The African
green monkey CV-1 cell line was originally obtained from
FIG. 7. Effect of IFN-a1 transgene treatment on anti-HSV-1 antibody
iters. Saline-, plasmid-vector-, and IFN-a1 transgene-treated mice
were infected with HSV-1 (1000 pfu/eye). Mice (n 5 3–7/group) were
sacrificed at day 30 postinfection and sera collected were assayed for
anti-HSV-1 titers by ELISA. Points represent the mean absorbance 6
SEM or mean alone (SEM # 10% of the mean). *P , 0.05 comparing
the wild-type mice treated to all other groups. A: total IgG. B: IgG2a.American Type Culture Collection (Manassas, VA). Cells
were maintained in RPMI 1640 (Gibco Life Technologies,Gaithersberg, MD) containing 5% fetal bovine serum
(Gibco) and an antibiotic/antimycotic solution (Gibco) in
an atmosphere of 37°C/5% CO2/95% humidity.
Adoptive transfer of spleen cells
Spleen cells obtained from WT or ICAM-1 ko mice
were incubated with 0.84% NH4Cl to osmotically lyse red
lood cells prior to introduction into recipient mice. In the
ase of adoptive transfer of cells into ICAM-1 ko mice,
3 107 spleen cells from WT mice were administered
ntraperitoneally into recipients in a volume of 100 ml of
PMI 1640 containing 10% fetal bovine serum. The
CAM-1 ko recipients were subsequently infected with
000 pfu/eye HSV-1 (McKrae strain) 24 h later and mon-
tored for cumulative survival. In the case of the TCRb ko
ice, recipients received 2 3 107 spleen cells from WT
r ICAM-1 ko donors in a volume of 100 ml of RPMI 1640
ontaining 10% fetal bovine serum. Seven days following
he transfer, the mice were infected with 1000 pfu/eye
SV-1 (McKrae strain) and monitored for cumulative sur-
ival.
lasmid DNA construct
The eukaryotic expression vector, pCMV-b, which con-
ains Escherichia coli b-galactosidase expressed under
the control of a human cytomegalovirus immediate-early
reporter gene, was purchased from Clontech Laborato-
ries (Palo Alto, CA) and used as the plasmid vector
control. A plasmid pCMV-IFNa1 was generated as pre-
viously described (Noisakran et al., 1999).
Virus infection
Mice were anesthetized with ketamine (200 mg/kg)
and xylazine (10 mg/kg) in PBS administered intraperito-
neally. Following scarification of the cornea, 100 mg of
lasmid DNA alone or plasmid DNA containing the
FN-a1 transgene was topically applied to the eye in a
olume of 3 ml of PBS. Twenty-four hours post DNA
pplication, the mice were again anesthetized, the cor-
ea was scarified, and 1000 plaque forming units (pfu) of
SV-1 was applied to each eye in a volume of 3 ml of
PBS. In one experiment (comparing ICAM-1 ko to WT
mice), the animals were not pretreated with DNA but only
infected with HSV-1 (1000 pfu/eye). Infection was verified
by swabbing the eyes 2–3 days postinfection and placing
the swabs in CV-1 monolayer cultures to observe any
cytopathic effect.
Histochemical staining for leukocyte infiltration
To evaluate the level of cellular infiltration following
HSV-1 infection in wild-type and ICAM-1 ko mice, the
eyes from infected mice days 6 and 16–20 postinfection
were fixed in alcoholic Z-fix (Anatech, Battle Creek, MI) at
room temperature for 48 h, transferred to 70% ethanol,
d
P
1
w
i
s
h
B
I
g
P
j
a
t
k
s
o
B
C
C
75ICAM-1, INTERFERON-a1, AND HERPES SIMPLEX VIRUS TYPE 1and processed on a MUP processor (Ventana Medical
Systems, Tucson, AZ) through graduated alcohols, XS-3
xylene substitute (Statlab Medical Products, Lewisville,
TX), and paraffin (Shandon Lipshaw, Pittsburgh, PA). The
processed eyes were then embedded in peel-away par-
affin, allowed to cool at room temperature, and cut at a
thickness of 5 mm using a Leitz 1512 microtome (Global
Medical Instrumentation, St. Paul, MN). The sections
were placed into a water bath (53°C), transferred onto
slides, and allowed to air dry. The sections were then
stained with hematoxylin and eosin using the MUP pro-
cessor (Ventana). The stained sections were dehydrated
in 100% ethanol, cleared in xylene, and coverslipped in
Permount.
Immunohistochemical staining for HSV-1 Ags
To determine the expression of HSV-1 Ag in the TG of
wild-type and ICAM-1 ko mice treated with plasmid vec-
tor alone or plasmid containing the IFN-a1 transgene, TG
from infected and uninfected (control) mice were col-
lected 6 days postinfection and processed as described
above. Anti-HSV-1 antibody was used to detect viral
antigen expression as previously reported (Noisakran
and Carr, 2000b).
Measurement of tissue HSV-1 titers
Mice were sacrificed at day 3 or 6 postinfection and
the eyes and TG were harvested, weighed, and homog-
enized in RPMI 1640 containing 5% fetal bovine serum
(Gibco) using a Ten Broeck homogenizer (Bellco, Vine-
land, NJ). The homogenate was clarified (10,000 g, 5 min)
and the clarified supernatants were titrated for infectious
virus on CV-1 cell monolayers in a 36- to 48-h plaque
assay.
Anti-HSV-1 antibody titers
HSV-1 virions used as coating antigen were generated
as previously described (Halford et al., 1996). Enzyme
immunoassay 96-well plates (EIA; Coster, Cambridge,
MA) were coated with HSV-1 virion protein (diluted in
PBS) in 100 ml of PBS for 18 h at 4°C. Wells were washed
once with PBS and blocked with 200 ml of 0.5% dry milk
issolved in PBS for 1 h at 37°C. After one rinsing with
BS, 100-ml samples of diluted mouse serum (1/50 to
/1600 in PBS) were added to the HSV-1 antigen-coated
ells and incubated for 1 h at 37°C. After six washings
n PBS containing 0.5% Tween 20 (polyoxyethylene-20-
orbitan monlaurate), 100 ml of goat anti-mouse IgG
eavy and light chain specific (diluted 1/500 in PBS;
io-Rad Laboratories, Richmond, CA), goat anti-mouse
gG1 (diluted 1/300 in PBS, Caltag Laboratories, Burlin-
ame, CA), or rat anti-mouse IgG2a (diluted 1/300 in PBS,
harmingen, San Diego, CA) alkaline-phosphatase-con-ugated antibodies was added to their respective wells in
volume of 100 ml and incubated for 30 min at 37°C.
CAfter six washings in PBS/Tween 20, 100 ml of p-nitro-
phenyl phosphate (Sigma Chemical Co., St. Louis, MO)
was added to each well, and colorimetric development
(optical density of 405 nm) was measured in an ELISA
plate reader (Molecular Devices, Sunnyvale, CA). To fur-
ther control for the determination of specific anti-HSV-1
antibody, uninfected CV-1 lysates were used as coating
antigen in replicate wells. The optical density readings
from these wells were subtracted from the HSV-1 anti-
gen-coated wells. At a 1/50 dilution, the optical density
readings for the CV-1 lysate-coated wells ranged from
0.025 to 0.110.
Statistics
The Mann–Whitney U test was used to determine
significant (P , 0.05) differences between the IFN-a1
ransgene- to plasmid-vector-treated groups or ICAM-1
o to wild-type control groups relative to cumulative
urvival. All other statistical analyses comparing vehicle-
r vector-treated mice with IFN-a1-treated animals in-
volved ANOVA and Tukey’s post hoc t test.
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